NovaBay Pharmaceuticals, Inc. Price to Tangible BV

Price to Tangible BV of NBY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Price to Tangible BV growth rates and interactive chart.


Highlights and Quick Summary

Current Price to Tangible BV of NovaBay Pharmaceuticals, Inc. is 0.0 (as of December 31, 2021)
  • Price to Tangible BV for the quarter ending June 30, 2022 was 2.34 (a 16.9% increase compared to previous quarter)
  • Year-over-year quarterly Price to Tangible BV decreased by -23.72%
  • Annual Price to Tangible BV for 2021 was 0.0 (a -100.0% decrease from previous year)
  • Annual Price to Tangible BV for 2020 was 1.99 (a -86.0% decrease from previous year)
  • Annual Price to Tangible BV for 2019 was 14.23 (a 441.24% increase from previous year)
Visit stockrow.com/NBY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Price to Tangible BV of NovaBay Pharmaceuticals, Inc.

Most recent Price to Tangible BVof NBY including historical data for past 10 years.

Interactive Chart of Price to Tangible BV of NovaBay Pharmaceuticals, Inc.

NovaBay Pharmaceuticals, Inc. Price to Tangible BV for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 2.34 2.0
2021 0.0 3.07 2.54 3.46 0.0
2020 1.99 2.11 35.55 0.0 1.99
2019 14.23 4.82 19.29 17.41 14.23
2018 2.63 4.82 5.75 6.47 2.63
2017 24.22 37.89 18.37 13.4 24.22
2016 4.29 6.66 0.0 0.0 4.29
2015 0.0 94.44 8.39 17.46 0.0
2014 16.92 7.5 4.35 4.48 16.92
2013 5.51 11.89 6.72 5.44 5.51
2012 2.37 5.08 6.03 5.04 2.37
2011 3.67 3.67

Business Profile of NovaBay Pharmaceuticals, Inc.

Sector: Healthcare
Industry: Biotechnology